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Abstract: This study was conducted to assess the association between the risks of spina 
bifida (SB) in relation to cigarette, alcohol, and caffeine consumption by women during the 
first month of pregnancy. Between 1988–2012, this multi-center case-control study 
interviewed mothers of 776 SB cases and 8,756 controls about pregnancy events and 
exposures. We evaluated cigarette smoking, frequency of alcohol drinking, and caffeine 
intake during the first lunar month of pregnancy in relation to SB risk. Logistic regression 
models were used to calculate adjusted odds ratios and 95% confidence intervals. Levels of 
cigarette smoking (1–9 and ≥10/day), alcohol intake (average ≥4 drinks/day) and caffeine 
intake (<1, 1, and ≥2 cups/day) were not likely to be associated with increased risk of SB. 
Further, results were similar among women who ingested less than the recommended 
amount of folic acid (400 μg/day). 
Keywords: spina bifida; alcohol consumption; caffeine consumption; cigarettes; folic acid; 
birth defects 
 
1. Introduction 
Spina bifida (SB), a neural tube defect (NTD), is a serious birth defect affecting approximately  
35 per 100,000 live births [1]. SB, like other NTDs, occurs when the neural tube fails to properly close 
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within the first 28 days after conception [2]. Maternal folic acid (FA) ingestion during the 
periconceptional period has been found to decrease the risk of giving birth to an infant with a  
NTD [3–6]. Based upon these findings, mandatory FA fortification of enriched cereal grains began in 
1998 in the U.S. and Canada [7]. After U.S. fortification, an increase in the blood folate levels of 
adults was observed [8,9], but not all women of childbearing age ingest the recommended amount of 
400 μg per day [7]. 
Because SB continues to occur among mothers who have ingested at least 400 μg per day of FA, 
other factors have been considered to explain the etiology of this birth defect. Among these, and based 
on their established or hypothesized teratogenic properties in humans, are cigarette smoking, alcohol 
drinking, and caffeine consumption [10–14]. Despite the positive association between maternal smoking 
and some birth defects, as well as the presence of known teratogenic chemicals in cigarettes [11], the 
association between maternal smoking and NTDs has been inconclusive, with study findings ranging 
from a protective effect to an increase in risk [10,11,14,15]. Extreme alcohol intake is a known human 
teratogen, causing Fetal Alcohol Syndrome in some exposed fetuses. NTDs are not a typical 
component of Fetal Alcohol Syndrome, but case reports suggest a possible link [16]. Epidemiological 
studies of moderate or low alcohol intakes and NTDs are inconclusive [11,14,17]. Caffeine intake in 
late gestation affects fetal cardiovascular function, but its effects in early gestation on organogenesis in 
general and neural tube development in particular are not known [18]. One epidemiologic study 
showed a slight increase in SB risk for all sources of caffeine [12], whereas three others showed no 
association [13,17,18]. 
FA metabolism is believed to be altered by exposure to cigarette smoke, alcohol, and caffeine. 
Smokers have lower plasma folate levels after adjustment for folate intake [19,20]. Alcohol interferes 
with folate transport and metabolism [21,22]. Lower plasma folate concentrations were observed in 
coffee drinkers in a cross-sectional study, but dietary folate or supplemental folic acid were not taken 
into account [23]. 
Utilizing data collected in the Boston University Slone Epidemiology Center Birth Defects Study, 
we tested the hypotheses that the risk of SB is associated with smoking, alcohol drinking, and coffee 
consumption during the first 28 days after the last menstrual period (LMP). Additionally, we 
investigated whether the risk would be greater in women who failed to ingest the recommended 
amount of folic acid. 
2. Methods 
2.1. Study Population 
The Slone Epidemiology Center Birth Defects Study is an on-going case-control study in North 
America, which began in 1976 and has been described in detail elsewhere [24–27]. Cases of birth 
defects were identified through birth hospitals, tertiary care centers, and birth defect registries in 
Massachusetts (1976+); Philadelphia, PA (1976+); Toronto, ON, Canada (1976–2005); San Diego 
County, CA (2001+); and parts of New York State (2004+). Beginning in 1990, therapeutic abortions 
after 12 weeks’ gestation and fetal deaths occurring after 20 weeks’ gestation were eligible for the 
study if identified; however, these pregnancies were not routinely ascertained. Beginning in 1993,  
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the study began ascertaining non-malformed controls from the same birth population that gave rise to 
cases. For the years prior to 1993, infants born with major malformations other than the one under 
study or those born with only minor malformations (e.g., hip clicks, toe anomalies) or nonstructural 
defects (e.g., cystic fibrosis) were used as controls. 
The present study was restricted to subjects interviewed between 1988 and 2012 when questions on 
changes in behaviors were asked. Cases of SB were excluded if they had a conjoined twin, 
chromosomal anomaly, Mendelian-inherited disorder, a known syndrome, amniotic bands, or a body 
wall defect. Cases were then reviewed by a clinical geneticist to ensure that they met the case 
definition. For 1988–1992, controls were infants with minor malformations or non-structural defects; 
for 1993–2012, control subjects were non-malformed infants. 
Maternal interviews were conducted within six months of delivery by trained study nurses; 
interviews were conducted in person until 1998 and, thereafter by telephone. The interview consisted 
of questions pertaining to socio-demographic factors, reproductive history, illness during pregnancy, 
details on prescription and over-the-counter medication use (including vitamins), and behavioral risk 
factors (e.g., cigarette smoking, alcohol drinking, and coffee consumption). Cases and controls whose 
maternal exposure information was missing were excluded from the specific analysis. To assess 
dietary intake, the long version Willett Food Frequency Questionnaire (FFQ) was administered from 
1988–1997; it was replaced with a modified, shortened, version in 1998. 
2.2. Smoking 
For the period beginning two months before and throughout pregnancy, mothers were asked the 
average number of cigarettes smoked per day before and after any changes in amount and the dates of 
those changes. Using the maternal-reported average and accounting for changes, we calculated an 
estimated average number of cigarettes smoked by determining the total number of cigarettes smoked 
during the 28 days after the LMP and then averaging the total number over the 28 days. Mothers were 
categorized according to the calculated average amount of cigarettes smoked per day (<1, 1–9, and ≥10) 
during the first lunar month after the LMP. 
2.3. Alcohol 
Mothers were asked about the average number of drinking days per week (frequency) and the 
average number of drinks per drinking day (intensity) of alcohol consumption two months prior to  
and during pregnancy, including changes in patterns of intake and the date of any such change. 
Maternal-reported averages and the change dates were used to estimate the total number of drinks per 
day and drinking days for the 28 days. A calculated average of the 28-day period was then determined. 
Mothers were categorized as a heavy drinker if they reported ≥4 drinks per day at any time during the 
first lunar month of pregnancy. Mothers were also classified, using the calculated average, according 
to their frequency of consumption in days per week (<1, 1, 2, and ≥3) and the intensity of consumption 
as the number of drinks per drinking day (<1, 1, 2, and ≥3) during the first lunar month after the LMP.   
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2.4. Coffee 
From 1998 through 2012, mothers were asked about the average number of cups of caffeinated 
coffee, tea, and soda consumed two months before and during their pregnancy; changes in frequency 
and the timing of any changes were also recorded. Before 1998, data on changes in frequency use were 
not collected. Changes in the interview occurring in 2005 led to different categorizations for tea and 
soda that were incompatible with previous years and therefore the main analysis was restricted to 
coffee intake from 1998 through 2012. To assess the influence of other sources of caffeine,  
a sensitivity analysis was performed using coffee, soda, and tea data from 1998 through 2005. For both 
analyses, mothers were categorized by the average number of caffeinated beverages/coffee consumed 
per day (none, <1, 1, and ≥2) during the first lunar month of pregnancy based on the total number over 
the 28 day period divided by 28 days, taking any changes into account. 
2.5. Smoking, Alcohol, and Coffee Interaction 
We then assessed potential interactions among the exposure variables. The interactions were 
examined by pairs (smoking/heavy drinking, smoking/coffee, heavy drinking/coffee) and all together 
(smoking/heavy drinking/coffee). Women who were in the highest exposure category for each variable 
were then compared to women who were in the reference category. 
2.6. Folic Acid Intake 
FA intake during the first lunar month of pregnancy was calculated by summing the average daily 
folic acid intake from supplements and fortified foods. Natural folate was also included, but discounted 
by 30% due to its lower bioavailability compared to synthetic folic acid [28]. The residual energy 
adjustment method [29] was used to adjust all dietary variables for total caloric intake. Participants 
were then categorized according to total folic acid intake (<400 and ≥400 μg/day). Participants with 
extreme caloric intakes (<500 or >4,000 kcal/day) or incomplete FFQ (≥3 missing items) were 
excluded from analyses involving folic acid intake, with two exceptions: Women who reported ≥400 μg 
per day of folic acid from vitamin supplements or who reported not taking any supplements containing 
folic acid were retained in the analysis. The former group was retained because those taking  
folic acid-containing vitamins would fall into the ≥ 400 μg per day stratum regardless of dietary intake. 
The latter group was retained based upon previous studies in which non-users would not likely reach 
the ≥ 400 μg per day stratum from diet alone [7]; therefore they were placed in the <400 μg per  
day category. 
2.7. Statistical Analysis 
Multiple logistic regression models were used to calculate crude (cORs) and adjusted odds ratios 
(aORs) and 95% confidence intervals (CIs) for each level of cigarette, alcohol and coffee exposure, 
with the non-use of each as the reference category. Sociodemographic factors that were considered as 
potential confounders included: maternal race/ethnicity (non-Hispanic White, non-Hispanic Black, 
Hispanic, other), maternal age (<20, 20–24, 25–29, 30–34, ≥35 years), maternal education (<12, 12,  
>12 years), study center (Boston, MA, USA; Philadelphia, PA, USA; Toronto, ON, Canada; San 
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Diego county, CA, USA; New York State, USA), body mass index (underweight, normal, overweight, 
obese; available for 1993 onward), non-steroidal anti-inflammatory (NSAID) drug use (yes, no), use of 
medication that is to known be a folic acid antagonist (yes, no), and amount of FA intake (<400 
μg/day, ≥400 μg/day). Variables that changed estimates by more than 10% were kept in the final 
model. A sub-analysis was performed for each exposure, in which we excluded women who had been 
diagnosed with diabetes prior to the index pregnancy. Data were stratified by study year  
(1988–1997 and 1998–2012) due to interview differences and by FA intake to assess for potential 
effect measure modification. All analyses were performed using SAS 9.2 software [30]. 
3. Results 
A total of 511 cases of SB and 868 controls (135 controls with minor malformations) were included 
for the years 1988 through 1997, while 265 cases of SB and 7,888 non-malformed controls were 
included for the years after 1998. Distributions of sociodemographic factors are presented in Table 1. 
For the years 1988 through 1997, of those mothers who were eligible and were asked to participate, 
mothers of 80% of cases and 68% of controls agreed to be interviewed [31]. For the years 1998 
through 2012, the equivalent proportions were 71% of cases and 67% of controls [32]. 
3.1. Smoking 
Due to missing smoking information, six cases and five controls were excluded from the 1988–1997 
smoking analysis and three controls were excluded from the 1998–2012 smoking analysis. For all 
years, cigarette smoking was more common among younger mothers and those with fewer years of 
education (Table 2). In the earlier years, smoking was more prevalent in cases (32%) compared to 
controls (22%), while in the later years little difference was seen between cases (18%) and controls 
(15%). Among the factors examined as possible confounders, study center, maternal education, 
NSAID use, and folic acid antagonist medication use, were found to meet the criterion for confounding 
(i.e., addition of the variable caused more than a 10% change in the estimate) for the years 1988 
through 1997 only maternal race/ethnicity and education met the criterion for confounding in the  
later years. 
For the years 1988 through 1997, no increased risk was observed for moderate smoking but there 
was a suggestion of an increased risk for heavier smokers (1–9 cigarettes/day: aOR: 1.2, 95% CI: 0.8, 
2.0; ≥10 cigarettes/day: aOR: 1.3, 95% CI: 0.9, 1.7) (Table 3). No increased risks were found in the 
later years (1–9 cigarettes/day: aOR: 1.1, 95% CI: 0.7, 1.8 and ≥10 cigarettes/day: aOR: 1.0, 95% CI: 
0.7, 1.6). When the data were stratified by folic acid intake, there was no appreciable change in risk 
among women with low FA intake (Figure 1). Furthermore, when women with pregestational diabetes 
were excluded from the smoking analysis there was no observable change in risks (1988–1993:  
1–9 cigarettes/day: aOR: 1.3, 95% CI: 0.8, 2.0; ≥10 cigarettes/day: aOR: 1.3, 95% CI: 0.9, 1.7;  
1998–2012: 1–9 cigarettes/day: aOR: 1.1, 95% CI: 0.7, 1.7; ≥10 cigarettes/day: aOR: 1.0, 95% CI: 0.6, 
1.6) (data not shown).  
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Table 1. Maternal Demographics of Spina Bifida Cases and Controls, Birth Defects Study, 1988–2012. 
 
1988–1997 1998–2012 
Controls SB Cases Controls SB Cases 
n % N % n % n % 
Total 868 
 
511 
 
7,888 
 
265 
 
Maternal race/ethnicity 
        
White, non-Hispanic 782 90.1 455 89.0 5,645 71.6 166 62.6 
Black, non-Hispanic 46 5.3 30 5.9 662 8.4 28 10.6 
Hispanic 17 2.0 16 3.1 896 11.4 50 18.9 
Other ǂ  23 2.6 10 2.0 672 8.5 21 7.9 
Missing 0 0.0 0 0.0 13 0.2 0 0.0 
Maternal age at conception 
        
<20 years 24 2.8 44 8.6 555 7.0 20 7.6 
20–24 years 91 10.5 102 20.0 1,149 14.6 43 16.2 
25–29 years 298 34.3 164 32.1 2,065 26.2 88 33.2 
30–34 years 325 37.4 144 28.2 2,641 33.5 72 27.2 
≥35 years 130 15.0 57 11.2 1,457 18.5 42 15.9 
Missing 0 0.0 0 0.0 21 0.3 0 0.0 
Maternal Education 
        
< 12 years 55 6.3 83 16.2 720 9.1 40 15.1 
12 years 187 21.5 181 35.4 1,452 18.4 64 24.2 
> 12 years 625 72.0 247 48.3 5,708 72.4 160 60.4 
Missing 1 0.1 0 0.0 8 0.1 1 0.4 
Study center (years in study) 
        
Boston, MA (1976+) 314 36.2 195 38.2 3,991 50.6 41 15.5 
Philadelphia (1976+) 186 21.4 155 30.3 1,567 19.9 91 34.3 
Toronto (1979–2005) 368 42.4 161 31.5 645 8.2 60 22.6 
San Diego (2001+) 0 0.0 0 0.0 1,131 14.3 38 14.3 
New York (2004+) 0 0.0 0 0.0 554 7.0 35 13.2 
BMI * (1993+) 
        
Underweight 60 6.9 11 2.2 376 4.8 7 2.6 
Normal 449 51.7 78 15.3 4,814 61.0 128 48.3 
Overweight 152 17.5 34 6.7 1,549 19.6 55 20.8 
Obese 67 7.7 27 5.3 965 12.2 60 22.6 
Missing 140 16.1 361 70.6 184 2.3 15 5.7 
Folic Acid 
        
<400μg 561 64.6 386 75.5 3,499 44.4 123 46.4 
≥400μg 297 34.2 112 21.9 4,222 53.5 131 49.4 
Missing 10 1.2 13 2.5 167 2.1 11 4.2 
ǂ  Other include mixed non-Hispanic, Native Hawaiian, Pacific Islander, Asian, Native American, or other  
* BMI: Body Mass Index defined as 
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Table 2. Maternal Demographics According to Control Subject’s Exposure During the First Month of Pregnancy, Birth Defects Study, 1988–2012. 
 
Smoking  
(1988–1997) 
Smoking  
(1998–2012) 
Alcohol Consumption  
(1988–1997) 
Alcohol Consumption  
(1998–2012) 
Coffee Consumption  
(1998–2012) 
<1 ≥1 <1 ≥1 No Yes <1 ≥1 <1 ≥1 
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
Maternal race/ethnicity 
    
  
   
White, non-Hispanic 606 (89.8) 176 (91.2) 4,721 (70.6) 924 (76.9) 354 (87) 428 (92.8) 2,769 (61.8) 2,876 (84.4) 3,777 (68.4) 1,868 (79) 
Black, non-Hispanic 38 (5.6) 8 (4.1) 554 (8.3) 108 (9) 26 (6.4) 20 (4.3) 487 (10.9) 175 (5.1) 579 (10.5) 170 (7.2) 
Hispanic 12 (1.8) 5 (2.6) 789 (11.8) 107 (8.9) 13 (3.2) 4 (0.9) 706 (15.8) 190 (5.6) 654 (11.8) 83 (3.5) 
Otherǂ  19 (2.8) 4 (2.1) 610 (9.1) 62 (5.2) 14 (3.4) 9 (2) 509 (11.4) 163 (4.8) 502 (9.1) 242 (10.2) 
Missing 0 (0) 0 (0) 12 (0.2) 1 (0.1) 0 (0) 0 (0) 9 (0.2) 4 (0.1) 11 (0.2) 2 (0.1) 
Maternal Age 
    
  
    
<20 years 10 (1.5) 14 (7.3) 393 (5.9) 162 (13.5) 14 (3.4) 10 (2.2) 435 (9.7) 120 (3.5) 473 (8.6) 82 (3.5) 
20–24 years 57 (8.4) 34 (17.6) 822 (12.3) 327 (27.2) 42 (10.3) 49 (10.6) 734 (16.4) 415 (12.2) 884 (16) 265 (11.2) 
25–29 years 228 (33.8) 70 (36.3) 1,751 (26.2) 314 (26.1) 152 (37.3) 146 (31.7) 1,202 (26.8) 863 (25.3) 1,473 (26.7) 592 (25) 
30–34 years 270 (40) 55 (28.5) 2,391 (35.8) 250 (20.8) 142 (34.9) 183 (39.7) 1,342 (30) 1,299 (38.1) 1,757 (31.8) 884 (37.4) 
≥35 years 110 (16.3) 20 (10.4) 1,308 (19.6) 149 (12.4) 57 (14) 73 (15.8) 753 (16.8) 704 (20.7) 918 (16.6) 539 (22.8) 
Missing 0 (0) 0 (0) 21 (0.3) 0 (0) 0 (0) 0 (0) 14 (0.3) 7 (0.2) 18 (0.3) 3 (0.1) 
Maternal Education 
    
  
   
< 12 years 29 (4.3) 26 (13.5) 498 (7.4) 222 (18.5) 31 (7.6) 24 (5.2) 584 (13) 136 (4) 564 (10.2) 156 (6.6) 
12 years 118 (17.5) 69 (35.8) 1,010 (15.1) 442 (36.8) 103 (25.3) 84 (18.2) 971 (21.7) 481 (14.1) 1,002 (18.1) 450 (19) 
> 12 years 527 (78.1) 98 (50.8) 5,170 (77.3) 538 (44.8) 273 (67.1) 352 (76.4) 2,918 (65.1) 2,790 (81.9) 3,950 (71.5) 1,758 (74.3) 
Missing 1 (0.1) 0 (0) 8 (0.1) 0 (0) 0 (0) 1 (0.2) 7 (0.2) 1 (0) 7 (0.1) 1 (0) 
Folic Acid 
    
  
    
<400 419 (62.1) 142 (73.6) 2,705 (40.5) 794 (66.1) 251 (61.7) 310 (67.2) 2,055 (45.9) 1,444 (42.4) 2,459 (44.5) 1,040 (44) 
400+ 249 (36.9) 48 (24.9) 3,848 (57.6) 374 (31.1) 151 (37.1) 146 (31.7) 2,300 (51.3) 1,922 (56.4) 2,945 (53.3) 1,277 (54) 
Missing  7 (1) 3 (1.6) 133 (2) 34 (2.8) 5 (1.2) 5 (1.1) 125 (2.8) 42 (1.2) 119 (2.2) 48 (2) 
Study center (years in study) 
    
  
   
Boston, MA (1976+) 243 (36) 71 (36.8) 3,324 (49.7) 667 (55.5) 133 (32.7) 181 (39.3) 2,182 (48.7) 1,809 (53.1) 2,619 (47.4) 1,372 (58) 
Philadelphia (1976+) 153 (22.7) 33 (17.1) 1,311 (19.6) 256 (21.3) 120 (29.5) 66 (14.3) 942 (21) 625 (18.3) 1,201 (21.7) 366 (15.5) 
Toronto (1979-2005) 279 (41.3) 89 (46.1) 536 (8) 109 (9.1) 154 (37.8) 214 (46.4) 334 (7.5) 311 (9.1) 435 (7.9) 210 (8.9) 
San Diego (2001+) 0 (0) 0 (0) 1,050 (15.7) 81 (6.7) 0 (0) 0 (0) 674 (15) 457 (13.4) 880 (15.9) 251 (10.6) 
New York (2004+) 0 (0) 0 (0) 465 (7) 89 (7.4) 0 (0) 0 (0) 348 (7.8) 206 (6) 388 (7) 166 (7) 
 
ǂ  Other include mixed non-Hispanic, Native Hawaiian, Pacific Islander, Asian, Native American, or other
Int. J. Environ. Res. Public Health 2013, 10 3270 
 
 
3.2. Alcohol 
Heavy drinking was examined by comparing mothers who drank ≥4 drinks per drinking day any 
time during the first month to mothers who drank less or none (Table 3). Maternal education was the 
only factor that met the confounding criterion in the earlier years while NSAID use and folic acid 
antagonist medication use were identified for the later years. Slightly more mothers of cases reported 
heavy alcohol consumption than mothers of controls, but the difference was confounded by maternal 
education in the early years and NSAID and folic acid antagonist medication in later years, resulting in 
ORs that approximated the null. There was no change in the risk after stratification by folic acid intake 
for women who had low intake levels (Figure 1). When women with pregestational diabetes were 
excluded, there was no change in aORs (1988–1993: aOR: 1.1, 95% CI: 0.7, 1.7; 1998–2012: aOR: 
1.2, 95% CI: 0.8, 2.0) (data not shown). 
One case from the early period and seven controls from the later period were excluded from the 
alcohol analysis on frequency and intensity due to missing data on alcohol intake. Sociodemographic 
factors meeting the criterion for confounding were study center, maternal education, and FA intake. 
For frequency and intensity of alcohol intake, the reference groups were defined as mothers reporting 
<1 drinking day per week and <1 drink per drinking day, respectively. When both frequency and 
intensity were considered together, women in both of these lower levels of intake constituted the 
reference group. Considered separately, neither frequency nor intensity measures was associated with 
increased SB risk, but women who were both frequent (≥3 days/week) and intense (≥3 drinks/day) 
drinkers were twice as prevalent among SB cases as controls (Table 4). However, the approximate  
2-fold crude odds (cOR = 2.1) of a frequent and intense drinking mother giving birth to an SB baby 
compared to the referent was confounded by FA intake, study center by year, and maternal education 
(aOR = 1.2). Additionally, the exclusion of women with pregestational diabetes did not result in any 
observable changes in aORs (data not shown). 
3.3. Coffee 
Caffeine intake from coffee consumption was analyzed for data between 1998 through 2012;  
no subjects were excluded from the coffee analysis due to missing data. Only study center met the 
criterion for confounding. Compared to mothers who reported consuming no coffee, no increase in risk 
was observed for daily coffee drinkers (<1 cup/day aOR: 0.7, 95% CI: 0.4, 1.1; 1 cup/day aOR: 0.9, 
95% CI: 0.6, 1.3; >2 cups/day aOR: 0.6, 95% CI: 0.3, 1.2). Furthermore, there was no observed change 
in risk among mothers who had low intake levels of folic acid (Figure 1). When other sources of 
caffeine were included for the sensitivity analysis, no elevated risks were identified (<1 cup/day aOR: 
0.8, 95% CI: 0.5, 1.4; 1 cup/day aOR: 0.9, 95% CI: 0.4, 1.6; ≥2 cups/day: aOR: 1.0, 95% CI: 0.6, 1.7). 
Exclusion of women with pregestational diabetes did not result in any observable changes in aORs  
(<1 cup/day aOR: 0.7, 95% CI: 0.5, 1.4; 1 cup/day aOR: 0.9, 95% CI: 0.6, 1.3; ≥2 cups/day: aOR: 0.6, 
95% CI: 0.3, 1.2) (data not shown). 
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Table 3. Association between Spina Bifida and Alcohol, Smoking, and Caffeine During 
the First Month of Pregnancy, Birth Defects Study, 1988–2012. 
 
Cases Controls 
cOR (95% CI) aOR (95% CI) 
n % n % 
Smoking 
      
1988–1997 1       
None 342 66.9 675 77.8 Ref Ref 
1–9 cig/day 38 7.4 53 6.1 1.4 (0.9, 2.2) 1.2 (0.8, 2.0) 
10+ cigs/day 125 24.5 135 15.6 1.8 (1.4, 2.4) 1.3 (0.9, 1.7) 
Missing 6 1.2 5 0.6 - - 
1998+ 2       
None 218 82.3 6,686 84.8 Ref Ref 
1–9 cig/day 22 8.3 522 6.6 1.3 (0.8, 2.0) 1.1 (0.7, 1.8) 
10+ cigs/day 25 9.4 677 8.6 1.1 (0.7, 1.7) 1.0 (0.7, 1.6) 
Missing 0  3 <0.1 - - 
Alcohol       
1988–1997 3       
No heavy drinking 456 89.2 805 92.7 Ref Ref 
Heavy drinking φ 55 10.8 63 7.3 1.5 (1.1, 2.3) 1.1 (0.7, 1.6) 
1998+ 4       
No heavy drinking 239 90.6 7,385 93.6 Ref Ref 
Heavy drinking φ 25 9.4 496 6.3 1.6 (1.0, 2.4) 1.2 (0.8, 2.0) 
Missing 1 0.4 7 <0.1 - - 
Smoking and Alcohol use       
1988–1997 5       
No smoking/ not heavy drinking 322 69.0 646 79.8 Ref Ref 
10+ cigs per day/ heavy drinking 29 6.2 24 3.0 2.4 (1.4, 4.2) 1.3 (0.7, 2.3) 
Missing 6 1.3 5 0.6 - - 
1998+ 6       
No smoking/ not heavy drinking 214 88.1 6,433 87.4 Ref Ref 
10+ cigs per day/ heavy drinking 11 4.5 149 2.0 2.2 (1.2, 4.2) 2.0 (1.0, 3.8) 
Missing 1 0.4 10 0.1 - - 
Caffeine from coffee 
      
1998+ 7       
None 205 77.4 5,523 70.0 Ref Ref 
<1 cup/day 21 7.9 844 10.7 0.7 (0.4, 1.1) 0.7 (0.4, 1.1) 
1 cup/day 31 11.7 1084 13.7 0.8 (0.5, 1.1) 0.9 (0.6, 1.3) 
2+ cups/day 8 3.0 437 5.5 0.5 (0.2, 1.0) 0.6 (0.3, 1.2) 
φ Heavy drinking: Maternal report of drinking an average 4+ drinks per sitting at any time during the first lunar month;  
1 Adjusted for maternal education, study center, NSAID use, and folic acid antagonist medication use; 2 Adjusted for 
maternal education and race/ethnicity; 3 Adjusted for maternal education; 4 Adjusted for NSAID use and folic acid 
antagonist medication use; 5 Adjusted for maternal education, study center, NSAID use, and folic acid antagonist 
medication use; 6 Adjusted for maternal education, race/ethnicity, NSAID use, and folic acid antagonist medication use; 7 
Adjusted for study center. 
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Figure 1. Adjusted Odds Ratios for Associations between Spina Bifida and Exposure for All Subjects and Subjects with <400μg Daily Folic 
Acid intake, Birth Defects Study 1988–2012. 
 
1 Adjusted for maternal education, study center, NSAID use, and folic acid antagonist medication use; 2 Adjusted for maternal education and race/ethnicity;  
3 Adjusted for maternal education; 4 Adjusted for NSAID use and folic acid antagonist medication use; 5 Adjusted for study center; 6 Adjusted for maternal 
education, study center, NSAID use, and folic acid antagonist medication use; 7 Adjusted for NSAID use and folic acid antagonist medication use. 
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Table 4. Association between Spina Bifida and Alcohol Consumption by Frequency and 
Intensity During the First Month of Pregnancy, Birth Defects Study, 1988–2012. 
   
Average number of drinking days per week 
Total 
<1 1 2 3+ 
A
v
er
a
g
e 
n
u
m
b
er
 o
f 
d
ri
n
k
s 
p
er
 d
ri
n
k
in
g
 d
a
y
 
<1 
Cases 424 0 0 0 424 
Controls 4,882 3 0 1 4,886 
cOR Ref - - - Ref 
aOR (95% CI) * - - - - - 
1 
Cases 76 15 9 14 114 
Controls 487 239 178 270 1,174 
cOR 1.8 0.7 0.6 0.6 1.1 
aOR (95% CI) * 0.7 (0.5, 1.1) 0.5 (0.3, 1.1) 0.5 (0.2, 1.1) 0.6 (0.3, 1.1) 0.7 (0.5, 0.9) 
2 
Cases 61 20 21 11 113 
Controls 615 383 297 198 1,493 
cOR 1.1 0.6 0.8 0.6 0.9 
aOR (95% CI) * 1 (0.7, 1.5) 0.6 (0.4, 1.1) 0.8 (0.5, 1.4) 0.6 (0.3, 1.2) 0.8 (0.6, 1.1) 
3+ 
Cases 52 36 15 22 125 
Controls 513 316 249 123 1,201 
cOR 1.2 1.3 0.7 2.1 1.2 
aOR (95% CI) * 0.7 (0.5, 1.0) 1 (0.6, 1.6) 0.3 (0.2, 0.6) 1.2 (0.6, 2.3) 0.7 (0.6, 1.0) 
Total 
Cases 613 71 45 47 
 
Controls 6,497 941 724 592 
 
cOR Ref 0.9 0.7 0.9 
 
aOR (95% CI) * - 0.8 (0.5, 1.1) 0.8 (0.4, 0.8) 0.7 (0.5, 1.3) 
 
* Adjusted for folic acid intake, study center by year, and maternal education. 
3.4. Smoking, Alcohol, and Coffee Interaction 
Because there was only one case in both the highest exposure group of caffeine and smoking, and 
none in the highest caffeine and heavy drinking, we did not assess these interactions in relation to SB 
risk. Women who reported both smoking 10+ cigarettes per day and heavy alcohol drinking were 
compared to women who did not smoke and were not heavy drinkers. Confounders identified in the 
early years were study center, maternal education, NSAID use, and folate antagonist medication use. 
In the later years confounders that met the criterion were maternal education, race/ethnicity, NSAID 
use, and folate antagonist medication use. Prior to 1998, there was no observed association for SB risk 
and the combination of 10+ cigarettes and heavy drinking (aOR: 1.3 95% CI: 0.7, 2.3). However, in 
the later years, a modest association was observed but the confidence interval included the null (aOR: 
2.0 95% CI: 1.0, 3.8). After stratifying women according to folic acid intake, there was little change in 
risk among mothers in both periods; however the elevated risk among mothers in the later years was 
more apparent (aOR: 2.3 95% CI: 1.1, 4.6) (Figure 1). 
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4. Discussion 
In this case-control study the risk for SB does not appear to be associated with cigarette smoking, 
alcohol consumption, and coffee consumption at the levels of intake observed in the study. These null 
results, with narrow CIs, are consistent with many previous reports [12–14,17,33–42] but are in 
contrast to a smaller number of studies with positive associations [11,12,38,43]. 
4.1. Smoking 
Our results for the earlier years of the study showed a small increase in risk for SB at each level of 
cigarette smoking, with a slight dose effect. In the later years, however, both levels of smoking 
exposure resulted in a null association with SB risk. The discontinuity between findings in the two 
time periods could be due to several factors. First, beginning in 1998, interviews were conducted over 
the phone as opposed to in-person. If in-person interviews elicit more accurate responses, then our 
findings from the more recent years would be more vulnerable to bias. A second possible explanation 
is the use of different controls prior to and following 1993; controls with minor malformations and 
certain medical conditions were used prior to 1993. However, a post hoc analysis of data collected 
before and after that change in the composition of control subjects revealed similar results (data not 
shown). Another possibility is uncontrolled confounding by factors that vary in distribution between 
the two time periods. For example, if FA is a true confounder and we tended to underestimate intakes, 
a larger proportion of women in the early years would be affected by such misclassification when 
intakes in general were lower, as observed in other population-based studies of intakes and blood 
folate levels [9]. Thus, uncontrolled confounding by FA intake would be greater in the earlier years. 
Finally, the percentage of heavier smokers has decreased over the past two decades in our study and in 
the general population of pregnant women [44–46]. If cigarette smoking has a threshold effect on SB 
risk, our null findings in the later years might be due the lower levels of smoking within the highest 
exposure category. The finding of no association has been observed in other studies [14,42,43]. One 
study broadly categorized smoking exposure as ≤5 and >5 cigarettes per day, while two others used 
finer categories of exposure (1–19, ≥20 and 1–14, 15–24, ≥25 cigarettes/day). 
4.2. Alcohol 
In the present study, neither frequent nor intense alcohol consumption was associated with SB risk, 
which is consistent with previous studies [11,17,34]. While the frequency of mothers who drank at 
least three drinks per drinking occasion and three or more days per week was more common among 
SB cases, this pattern was due to confounding by FA intake, study center and period, and education. 
With regard to the impact of heavy drinking during the first 28 days after LMP, we found no 
association with the risk of SB. Results of previous studies using similar categories of exposure have 
been inconclusive. One study observed an increase in the risk of NTDs (OR: 1.7, 95% CI: 0.8, 3.6) [11] 
while two studies of SB reported null results [14,17]. 
  
Int. J. Environ. Res. Public Health 2013, 10 3275 
 
 
4.3. Coffee 
We found that maternal exposure to caffeine from coffee was not associated with an increased risk 
of SB. Rather, ORs for varying levels of intake were all below 1.0, but the 95% confidence intervals 
included 1.0. Furthermore, we observed very little confounding of our risk estimates for caffeine. 
Consistent with our findings, two previous studies found no association between NTDs and coffee or 
caffeine [13,35] and one found a suggestion of a protective effect [36]. In one previous study, there 
was a slight increase in the risk for SB among mothers who consumed coffee [12]. However, similar to 
our finding, there was no dose effect observed, which the authors cited as evidence against a causal 
association [12]. 
4.4. Smoking, Alcohol, and Coffee Interaction 
The combination of smoking 10+ cigarettes per day and heavy drinking was not associated with SB 
risk in the earlier years of the study, but a doubling in risk in the later years. As described above in our 
discussion of cigarette smoking results, the discontinuity in our findings between the two time periods 
could be due to different interviewing formats or uncontrolled confounding. Previous studies of 
smoking and alcohol exposures in relation to NTDs did not examine the interaction of these two 
variables [14,17,42,43], but one study did show an increase (aOR: 12.7 95% CI: 3.5, 45.3) for the risk 
of congenital cardiac defects and the interaction of maternal binge drinking (≥5 drinks on at least one 
occasion) and smoking (yes, no) in the three months prior to pregnancy [47]. 
4.5. Bias/Limitations 
There were limitations to our study. First, reported exposures suggest that only a small percentage 
of women are in the highest exposure group, which limits our ability to study the effects of these 
exposures and decreases the precision of our estimates. The problem was exacerbated when the data 
were stratified by FA intake. Additionally, data on exposure were collected by maternal self-report 
which likely has high sensitivity but low specificity in that some women may under-report. Such 
misclassification may be greater for exposures with the most stigma [48] in pregnancy (e.g., cigarettes 
and alcohol). If mothers of cases are more likely to deny high level use, effect estimates would be 
biased downward. Studies have shown that reliability of self-reported smoking during pregnancy is 
generally good [49–51], but subjects may underreport the amount they smoke [52,53]. Alcohol intake 
in pregnancy was found to be under-reported by 44% in one study [48]. In a study examining coffee 
intake reporting, it was found that amounts reported by FFQ correlated well with amounts reported by 
daily food diaries; however, absolute intake differed between the FFQ and the daily food diary [54]. 
Accuracy of reporting exposure to cigarettes, alcohol, and coffee is further complicated by our early 
pregnancy exposure window, which is a time when women often change their exposure patterns. 
Further, exposures in the earliest days of lunar month two may be etiologically relevant but were not 
considered in our exposure algorithms. Therefore, we cannot rule out the possibility of misclassification 
of our exposures. 
Power was maximized and bias minimized through systematic approaches in the study design. This 
study included a large number of cases and controls to maximize the number of subjects within each 
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stratum of exposure. During maternal interviews, information was gathered on frequency, quantity, 
and timing through the use of a standardized questionnaire and detailed support material  
(e.g., calendars) to help participants give complete and accurate responses. To minimize any potential 
bias stemming from maternal recall, reporting accuracy was maximized for both cases and controls 
through highly structured interviews conducted within six months of birth or termination by skilled 
and experienced nurse interviewers who were unaware of the study hypotheses. 
5. Conclusions 
We have investigated the association between the risk of SB and periconceptional cigarette, alcohol, 
and coffee consumption, using a large geographically diverse case-control study. Our findings suggest 
that there is no increased risk for SB among women who consumed cigarettes, alcohol, and caffeine. 
This observation held true among women who did not consume the recommended amount of folic 
acid. Despite the fact that our findings are similar to those of previous studies, the results should still 
be interpreted cautiously due to limitations, including low precision for the highest levels of intake. 
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